Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I
- 1 August 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 121 (2) , 155-160
- https://doi.org/10.1111/j.1365-2133.1989.tb01794.x
Abstract
Normal human and psoriatic epidermal phospholipase A2 (PLA2) was inhibited by human recombinant lipocortin I when the substrate was present in a several million-fold molar excess. Inhibition was not total, even at relatively high concentrations of lipocortin I. It is therefore suggested that human epidermis contains two species of PLA2: one that is controlled by lipocortin I and one that is not.This publication has 23 references indexed in Scilit:
- Purification and characterization of a 32‐kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cellsFEBS Letters, 1987
- Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependentFEBS Letters, 1987
- Purification of three forms of lipocortin from bovine lungCell Calcium, 1987
- Lipocortin‐like anti‐phospholipase A2 activity of endonexinFEBS Letters, 1987
- The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeatsCell, 1986
- Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activityNature, 1986
- Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczemaBritish Journal of Dermatology, 1985
- Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid actionBritish Journal of Dermatology, 1984
- Confirmation of raised phospholipase A2 activity in the uninvolved skin of psoriasisBritish Journal of Dermatology, 1984
- Dexamethasone receptors in human epidermisBritish Journal of Dermatology, 1982